Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Ranitidine only impact rm9m. the rest of big impact is amortization of PhIS which has been warned in Q3. cash flow remain healthy. if later drop too much then i will expect some technical rebound. while commenting this, i am still holding share with average price rm2.3